artenimol has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gan, J; Jiang, M; Li, L; Li, Y; Ling, X; Qi, L; Song, C; Song, D; Wu, Y | 1 |
1 other study(ies) available for artenimol and Esophageal Squamous Cell Carcinoma
| Article | Year |
|---|---|
Dihydroartemisinin mediating PKM2-caspase-8/3-GSDME axis for pyroptosis in esophageal squamous cell carcinoma.
Topics: Animals; Artemisinins; Carrier Proteins; Caspase 3; Caspase 8; Caspase Inhibitors; Cell Line, Tumor; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Gene Knockdown Techniques; Humans; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Pyroptosis; Receptors, Estrogen; Signal Transduction; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Up-Regulation; Xenograft Model Antitumor Assays | 2021 |